AIADX
Price
$10.48
Change
-$0.18 (-1.69%)
Updated
Jun 9 closing price
Net Assets
1.99B
FIPDX
Price
$9.22
Change
+$0.02 (+0.22%)
Updated
Jun 9 closing price
Net Assets
11.57B
Interact to see
Advertisement

AIADX vs FIPDX

Header iconAIADX vs FIPDX Comparison
Open Charts AIADX vs FIPDXBanner chart's image
AIADX vs FIPDX Comparison Chart in %
View a ticker or compare two or three
VS
AIADX vs. FIPDX commentary
Jun 10, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AIADX is a Hold and FIPDX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FIPDX has more cash in the bank: 11.6B vs. AIADX (1.99B). AIADX pays higher dividends than FIPDX: AIADX (4.48) vs FIPDX (3.79). AIADX was incepted earlier than FIPDX: AIADX (9 years) vs FIPDX (14 years). AIADX (0.29) is less costly to investors than FIPDX (0.05). AIADX is a more actively managed with annual turnover of: 44.00 vs. FIPDX (19.00). AIADX (0) and FIPDX (0) have matching initial minimum investment requirements. AIADX annual gain was more profitable for investors over the last year : 5.04 vs. FIPDX (4.78). AIADX (4.72) and FIPDX (4.62) have equivalent 5 years return.
AIADXFIPDXAIADX / FIPDX
Total Expense Ratio0.290.05580%
Annual Report Gross Expense Ratio0.290.05580%
Fund Existence9 years14 years-
Gain YTD1.1580.888130%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets1.99B11.6B17%
Annual Yield % from dividends4.483.79118%
Returns for 1 year5.044.78106%
Returns for 3 years11.9511.90100%
Returns for 5 years4.724.62102%
Returns for 10 yearsN/A20.11-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BMHL5.310.93
+21.23%
Bluemount Holdings Ltd
FIZZ37.191.43
+4.01%
National Beverage Corp
AWK125.533.04
+2.48%
American Water Works Company
GSM3.840.01
+0.26%
Ferroglobe PLC
ERNA6.80-0.59
-7.98%
Ernexa Therapeutics Inc.